Mitochondria: A Common Target for Genetic Mutations and Environmental Toxicants in Parkinson’s Disease

Parkinson’s disease (PD) is a devastating neurological movement disorder. Since its first discovery 200 years ago, genetic and environmental factors have been identified to play a role in PD development and progression. Although genetic studies have been the predominant driving force in PD research over the last few decades, currently only a small fraction of PD cases can be directly linked to monogenic mutations. The remaining cases have been attributed to other risk associated genes, environmental exposures and gene–environment interactions, making PD a multifactorial disorder with a complex etiology. However, enormous efforts from global research have yielded significant insights into pathogenic mechanisms and potential therapeutic targets for PD. This review will highlight mitochondrial dysfunction as a common pathway involved in both genetic mutations and environmental toxicants linked to PD.

• Publication year

  2017

• Venue

  Frontiers in Genetics

• Publication date

  2017-11-17

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.3389/fgene.2017.00177PMID 29204154PMCID 5698285
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Parkinson's disease].

  2022influential reference
• Predicting Parkinson's disease

  2018cited by this paper
• Trio approach reveals higher risk of PD in carriers of severe vs. mild GBA mutations.

  2018cited by this paper
• Genetics of Parkinson's disease

  2018influential reference
• The two-century journey of Parkinson disease research

  2017cited by this paper
• Prying into the Prion Hypothesis for Parkinson's Disease

  2017cited by this paper
• Editor’s Highlight: Base Excision Repair Variants and Pesticide Exposure Increase Parkinson’s Disease Risk

  2017cited by this paper
• Mitochondrial division inhibitor-1 is neuroprotective in the A53T-α-synuclein rat model of Parkinson’s disease

  2017cited by this paper
• Early life exposure to permethrin: a progressive animal model of Parkinson's disease.

  2017cited by this paper
• Parkinson's Disease Is Not Simply a Prion Disorder

  2017cited by this paper
• Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production

  2017cited by this paper
• PINK1 Primes Parkin-Mediated Ubiquitination of PARIS in Dopaminergic Neuronal Survival.

  2017cited by this paper
• VPS35, the Retromer Complex and Parkinson’s Disease

  2017cited by this paper
• Manganese exposure induces neuroinflammation by impairing mitochondrial dynamics in astrocytes

  2017cited by this paper
• PLA2G6 accumulates in Lewy bodies in PARK14 and idiopathic Parkinson's disease.

  2017cited by this paper
• The pesticide dieldrin disrupts proteins related to oxidative respiration and mitochondrial stress in the central nervous system

  2017cited by this paper
• Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy

  2017cited by this paper
• A nonsense mutation in CHCHD2 in a patient with Parkinson disease

  2016cited by this paper
• Defending the mitochondria: The pathways of mitophagy and mitochondrial-derived vesicles.

  2016cited by this paper
• Autophagy and Alpha‐Synuclein: Relevance to Parkinson's Disease and Related Synucleopathies

  2016cited by this paper
• α-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson’s disease

  2016influential reference
• Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism–dystonia

  2016cited by this paper
• Genetics in Parkinson disease: Mendelian versus non‐Mendelian inheritance

  2016influential reference
• Loss of Parkinson's disease-associated protein CHCHD2 affects mitochondrial crista structure and destabilizes cytochrome c

  2016influential reference
• Survival and dementia in GBA‐associated Parkinson's disease: The mutation matters

  2016cited by this paper
• Enteric neurons from Parkinson’s disease patients display ex vivo aberrations in mitochondrial structure

  2016cited by this paper
• Metals and Neurodegeneration

  2016cited by this paper
• High expression of α-synuclein in damaged mitochondria with PLA2G6 dysfunction

  2016cited by this paper
• Untangling the Manganese-α-Synuclein Web

  2016cited by this paper
• PINK1 disables the anti-fission machinery to segregate damaged mitochondria for mitophagy

  2016cited by this paper
• DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser parkinsonism: a genome-wide linkage and association study.

  2016cited by this paper
• Mitochondrial DNA in CSF distinguishes LRRK2 from idiopathic Parkinson's disease.

  2016cited by this paper
• Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice.

  2015cited by this paper
• Mitochondrial targeting sequence variants of the CHCHD2 gene are a risk for Lewy body disorders

  2015cited by this paper
• MNRR1 (formerly CHCHD2) is a bi-organellar regulator of mitochondrial metabolism.

  2015cited by this paper
• VPS35 Deficiency or Mutation Causes Dopaminergic Neuronal Loss by Impairing Mitochondrial Fusion and Function.

  2015influential reference
• LRRK2 Pathways Leading to Neurodegeneration

  2015cited by this paper
• Parkin loss leads to PARIS-dependent declines in mitochondrial mass and respiration

  2015cited by this paper
• LRRK2 overexpression alters glutamatergic presynaptic plasticity, striatal dopamine tone, postsynaptic signal transduction, motor activity and memory.

  2015cited by this paper
• Iron overload triggers mitochondrial fragmentation via calcineurin-sensitive signals in HT-22 hippocampal neuron cells.

  2015cited by this paper
• F-box protein 7 mutations promote protein aggregation in mitochondria and inhibit mitophagy.

  2015cited by this paper
• Alpha-Synuclein Regulates Neuronal Levels of Manganese and Calcium.

  2015cited by this paper
• Parkinson’s disease-associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes

  2015cited by this paper
• Pharmacological Chaperones and Coenzyme Q10 Treatment Improves Mutant β-Glucocerebrosidase Activity and Mitochondrial Function in Neuronopathic Forms of Gaucher Disease

  2015cited by this paper
• The neurotoxicity of organochlorine and pyrethroid pesticides.

  2015cited by this paper
• α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson's disease.

  2015cited by this paper
• Identification of dopaminergic neurons of the substantia nigra pars compacta as a target of manganese accumulation.

  2015cited by this paper
• The three ‘P’s of mitophagy: PARKIN, PINK1, and post-translational modifications

  2015cited by this paper
• Manganese-Induced Parkinsonism Is Not Idiopathic Parkinson's Disease: Environmental and Genetic Evidence.

  2015cited by this paper
• Manganese-Induced Parkinsonism and Parkinson’s Disease: Shared and Distinguishable Features

  2015influential reference
• CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study.

  2015cited by this paper
• Differential effects of severe vs mild GBA mutations on Parkinson disease

  2015cited by this paper
• A53T Human α-Synuclein Overexpression in Transgenic Mice Induces Pervasive Mitochondria Macroautophagy Defects Preceding Dopamine Neuron Degeneration

  2015influential reference
• A new F‐box protein 7 gene mutation causing typical Parkinson's disease

  2015cited by this paper
• The Upshot of LRRK2 Inhibition to Parkinson’s Disease Paradigm

  2015cited by this paper
• LRRK2 functions in synaptic vesicle endocytosis through a kinase-dependent mechanism

  2015cited by this paper
• α-Synuclein Shows High Affinity Interaction with Voltage-dependent Anion Channel, Suggesting Mechanisms of Mitochondrial Regulation and Toxicity in Parkinson Disease*

  2015influential reference
• Correlation between the biochemical pathways altered by mutated parkinson-related genes and chronic exposure to manganese.

  2014cited by this paper
• Functional interplay between Parkin and Drp1 in mitochondrial fission and clearance.

  2014influential reference
• α-Synuclein Is Localized to Mitochondria-Associated ER Membranes

  2014cited by this paper
• Increasing microtubule acetylation rescues axonal transport and locomotor deficits caused by LRRK2 Roc-COR domain mutations

  2014cited by this paper
• Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases

  2014cited by this paper
• A new pathway for mitochondrial quality control: mitochondrial‐derived vesicles

  2014cited by this paper
• In vivo evidence of pathogenicity of VPS35 mutations in the Drosophila

  2014cited by this paper
• Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinson’s disease

  2014cited by this paper
• Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease.

  2014cited by this paper
• Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease

  2014cited by this paper
• Glucocerebrosidase depletion enhances cell-to-cell transmission of α-synuclein

  2014cited by this paper
• Proteomic analysis.

  2014cited by this paper
• Region specific mitochondrial impairment in mice with widespread overexpression of alpha-synuclein.

  2014cited by this paper
• Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65

  2014cited by this paper
• Beyond the mitochondrion: cytosolic PINK1 remodels dendrites through Protein Kinase A

  2014cited by this paper
• Behavioral Deficits and Striatal DA Signaling in LRRK2 p.G2019S Transgenic Rats: A Multimodal Investigation Including PET Neuroimaging

  2014cited by this paper
• Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegeneration

  2014cited by this paper
• Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes.

  2014influential reference
• Deregulation of Mitochondria-Shaping Proteins Opa-1 and Drp-1 in Manganese-Induced Apoptosis

  2014cited by this paper
• PINK1 Loss-of-Function Mutations Affect Mitochondrial Complex I Activity via NdufA10 Ubiquinone Uncoupling

  2014cited by this paper
• LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson's disease patients: reversal by gene correction.

  2014cited by this paper
• Aldehyde dehydrogenase variation enhances effect of pesticides associated with Parkinson disease

  2014cited by this paper
• Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice.

  2014influential reference
• The effects of pdr1, djr1.1 and pink1 loss in manganese-induced toxicity and the role of α-synuclein in C. elegans.

  2014cited by this paper
• LRRK2: Cause, Risk, and Mechanism

  2013cited by this paper
• The Parkinson’s disease genes Fbxo7 and Parkin interact to mediate mitophagy

  2013cited by this paper
• The function of α-synuclein.

  2013cited by this paper
• Functional interaction of Parkinson's disease-associated LRRK2 with members of the dynamin GTPase superfamily

  2013cited by this paper
• Paths from Pesticides to Parkinson's

  2013cited by this paper
• Glucocerebrosidase inhibition causes mitochondrial dysfunction and free radical damage

  2013cited by this paper
• PINK1 is degraded through the N-end rule pathway

  2013cited by this paper
• Environmental risk factors

  2013cited by this paper
• G51D α‐synuclein mutation causes a novel Parkinsonian–pyramidal syndrome

  2013cited by this paper
• Absorption of Manganese and Iron in a Mouse Model of Hemochromatosis

  2013cited by this paper
• Manganese and the brain.

  2013influential reference
• Inhibition of excessive mitochondrial fission reduced aberrant autophagy and neuronal damage caused by LRRK2 G2019S mutation.

  2013cited by this paper
• Alpha-Synuclein Transmission and Mitochondrial Toxicity in Primary Human Foetal Enteric Neurons In Vitro

  2013cited by this paper
• Mitochondria and Quality Control Defects in a Mouse Model of Gaucher Disease—Links to Parkinson’s Disease

  2013cited by this paper
• Monomer DJ-1 and Its N-Terminal Sequence Are Necessary for Mitochondrial Localization of DJ-1 Mutants

  2013cited by this paper
• Manganese neurotoxicity and the role of reactive oxygen species.

  2013cited by this paper
• A Dimeric PINK1-containing Complex on Depolarized Mitochondria Stimulates Parkin Recruitment*

  2013cited by this paper
• Gene-environment interactions in Parkinson's disease: specific evidence in humans and mammalian models.

  2013cited by this paper
• Alpha‐synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease

  2013cited by this paper

• Emerging prospects and consequences of environmental neurotoxic pollutants in the vertebrate system

  2026cites this paper
• An update on the monogenic causes of Parkinson's disease: Impact on patient stratification and personalised medicine.

  2026cites this paper
• Interplay Between Retroviral Element De-repression and Wnt/β-Catenin Pathway in Cellular Models of Parkinson’s Disease

  2026cites this paper
• Effect of paraquat-induced toxicity and the therapeutic potentials of Moringa oleifera and Moringa stenopetala leaf alkaloid extracts

  2025cites this paper
• Adaptive immunity in the pathogenesis and treatments of Parkinson’s disease

  2025cites this paper
• Imbalanced mitochondrial dynamics in human PD and α-synuclein mouse brains.

  2025cites this paper
• Evaluation of the Protective Effects of Noscapine on Paraquat-Induced Parkinson's Disease in Rats

  2025influential citation
• Nanotechnology in Parkinson’s Disease: overcoming drug delivery challenges and enhancing therapeutic outcomes

  2025cites this paper
• Neuroinflammatory Mechanisms and Vocalization Biomarkers in the Pink1−/− Preclinical Model of Parkinson’s Disease

  2025cites this paper
• Inhibition of Mitochondrial Complex III Causes Dopaminergic Neurodegeneration by Redox Stress in Caenorhabditis elegans

  2025cites this paper
• The Body, the Brain, the Environment, and Parkinson’s Disease

  2024cites this paper
• Role of NLRP3 in Parkinson's disease: Specific activation especially in dopaminergic neurons

  2024cites this paper
• Superoxide dismutase and neurological disorders

  2024cites this paper
• The research landscape concerning environmental factors in neurodevelopmental disorders: Endocrine disrupters and pesticides-A review.

  2024cites this paper
• Bioengineered Exosomes: Cellular Membrane-Camouflaged Biomimetic Nanocarriers for Parkinson's Disease Management.

  2024cites this paper
• Nuclear pore and nucleocytoplasmic transport impairment in oxidative stress-induced neurodegeneration: relevance to molecular mechanisms in Pathogenesis of Parkinson’s and other related neurodegenerative diseases

  2024cites this paper
• Unknown roles of tau pathology in neurological disorders. Challenges and new perspectives.

  2024cites this paper
• USP14 inhibition enhances Parkin-independent mitophagy in iNeurons

  2024cites this paper
• Mechanisms Mediating the Combined Toxicity of Paraquat and Maneb in SH-SY5Y Neuroblastoma Cells

  2024cites this paper
• How Parkinson’s Disease-Linked LRRK2 Mutations Affect Different CNS Cell Types

  2024cites this paper
• Fraction of C. d. collilineatus venom containing crotapotin protects PC12 cells against MPP + toxicity by activating the NGF-signaling pathway

  2024cites this paper
• Optimization of Parkinson's disease therapy with plant extracts and nutrition’s evolving roles

  2024cites this paper
• Nr1h4 and Thrb ameliorate ER stress and provide protection in the MPTP mouse model of Parkinson’s

  2024cites this paper
• Dithianon exposure induces dopaminergic neurotoxicity in Caenorhabditis elegans.

  2023cites this paper
• Decoding mitochondrial-nuclear (epi)genome interactions: the emerging role of ncRNAs.

  2023cites this paper
• Assessment of tRNAThr and tRNAGln Variants and Mitochondrial Functionality in Parkinson’s Disease (PD) Patients of Tamil Nadu Population

  2023cites this paper
• Disruption of Dopamine Homeostasis Associated with Alteration of Proteins in Synaptic Vesicles: A Putative Central Mechanism of Parkinson’s Disease Pathogenesis

  2023cites this paper
• Consequences of Disturbing Manganese Homeostasis

  2023cites this paper
• Exposome and unhealthy aging: environmental drivers from air pollution to occupational exposures

  2023cites this paper
• Neuroprotective Effect of Curcumin on the Rat Model of Parkinson’s Disease Induced by Rotenone via Modulating Tyrosine Hydroxylase and Dopa Decarboxylase Expression Levels

  2023cites this paper
• Progress in Mechanisms, Pathways and Cohort Studies About the Effects of PM_2.5 Exposure on the Central Nervous System

  2023cites this paper
• Synergistic effects of lipopolysaccharide and rotenone on dopamine neuronal damage in rats

  2023cites this paper
• α-Synuclein oligomers and fibrils: partners in crime in synucleinopathies

  2023cites this paper
• TRPMLs and TPCs: Targets for lysosomal storage and neurodegenerative disease therapy?

  2022cites this paper
• Single-cell analysis of gene expression in the substantia nigra pars compacta of a pesticide-induced mouse model of Parkinson’s disease

  2022cites this paper
• The Wnt/β-catenin signaling: a multifunctional target for neuroprotective and regenerative strategies in Parkinson’s disease

  2022cites this paper
• Alpha-Synuclein: The Spark That Flames Dopaminergic Neurons, In Vitro and In Vivo Evidence

  2022cites this paper
• Parkinson's disease: connecting mitochondria to inflammasomes.

  2022cites this paper
• Long-term exposure to azoxystrobin induces immunodeficiency in fish that are vulnerable to subsequent rhabdovirus infection.

  2022cites this paper
• Iron Brain Menace: The Involvement of Ferroptosis in Parkinson Disease

  2022cites this paper
• Natriuretic peptides are neuroprotective on in vitro models of PD and promote dopaminergic differentiation of hiPSCs-derived neurons via the Wnt/β-catenin signaling

  2021cites this paper
• Naringenin alleviates paraquat-induced dopaminergic neuronal loss in SH-SY5Y cells and a rat model of Parkinson's disease.

  2021cites this paper
• Contribution of the Nrf2 Pathway on Oxidative Damage and Mitochondrial Failure in Parkinson and Alzheimer’s Disease

  2021cites this paper
• Recalling the pathology of Parkinson's disease; lacking exact figure of prevalence and genetic evidence in Asia with an alarming outcome: A time to step‐up

  2021cites this paper
• Neuroprotective Potential of Mild Uncoupling in Mitochondria. Pros and Cons

  2021cites this paper
• Potential Common Genetic Risks of Sporadic Parkinson’s Disease and Amyotrophic Lateral Sclerosis in the Han Population of Mainland China

  2021cites this paper
• Baicalein Exerts Anti-Neuroinflammatory Effects by Inhibiting the TLR4-ROS /NF-κB-NLRP3 Inflammasome

  2021cites this paper
• The Impact of Environmental Factors on Monogenic Mendelian Diseases.

  2021cites this paper
• Defective Mitochondrial Dynamics Underlie Manganese-Induced Neurotoxicity

  2021cites this paper
• Mfn2 Overexpression Attenuates MPTP Neurotoxicity In Vivo

  2021cites this paper
• Mitochondrial DNA Mutagenesis: Feature of and Biomarker for Environmental Exposures and Aging

  2021cites this paper
• Nutrition and Lifestyle Interventions for Managing Parkinson’s Disease: A Narrative Review

  2020cites this paper
• Muscle Stem Cell-Derived Extracellular Vesicles Reverse Hydrogen Peroxide-Induced Mitochondrial Dysfunction in Mouse Myotubes

  2020cites this paper
• Vagal motoneurons in Parkinson's disease

  2020cites this paper
• Behavioral Tests in Neurotoxin-Induced Animal Models of Parkinson’s Disease

  2020cites this paper
• Deletion of DJ-1 in rats affects protein abundance and mitochondrial function at the synapse

  2020cites this paper
• Ketotherapeutics for neurodegenerative diseases

  2020cites this paper
• Effects of deoxynivalenol on mitochondrial dynamics and autophagy in pig spleen lymphocytes.

  2020cites this paper
• Mitochondrial calcium dysfunction contributes to autophagic cell death induced by MPP+ via AMPK pathway.

  2019cites this paper
• Contributions of VPS35 Mutations to Parkinson's Disease.

  2019cites this paper
• Interplay between NAD+ and acetyl‑CoA metabolism in ischemia-induced mitochondrial pathophysiology.

  2019cites this paper
• Exosome release and neuropathology induced by α-synuclein: new insights into protective mechanisms of Drp1 inhibition

  2019cites this paper
• The Overcrowded Crossroads: Mitochondria, Alpha-Synuclein, and the Endo-Lysosomal System Interaction in Parkinson’s Disease

  2019cites this paper
• Emerging concepts of mitochondrial dysfunction in Parkinson's disease progression: Pathogenic and therapeutic implications.

  2019cites this paper
• IH LOSS OF FUNCTION AS A PATHOGENIC MECHANISM UNDERLYING THE SELECTIVE VULNERABILITY OF NIGRAL DOPAMINE NEURONS IN PARKINSON ’ S DISEASE

  2019cites this paper
• New Insights on the Role of Manganese in Alzheimer’s Disease and Parkinson’s Disease

  2019cites this paper
• Three-dimensional modeling of human neurodegeneration: brain organoids coming of age

  2019cites this paper
• Enhanced mitochondrial inhibition by 3,4‐dihydroxyphenyl‐acetaldehyde (DOPAL)‐oligomerized α‐synuclein

  2019cites this paper
• The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson’s disease

  2019cites this paper
• NEAT1 is overexpressed in Parkinson’s disease substantia nigra and confers drug-inducible neuroprotection from oxidative stress

  2019cites this paper
• Genetic Defects in Mitochondrial Dynamics in Caenorhabditis elegans Impact Ultraviolet C Radiation- and 6-hydroxydopamine-Induced Neurodegeneration

  2019cites this paper
• Mitochondrial Biology and Medicine

  2019cites this paper
• DNA methylation changes associated with Parkinson’s disease progression: outcomes from the first longitudinal genome-wide methylation analysis in blood

  2019cites this paper
• Nicotinamide adenine dinucleotide emerges as a therapeutic target in aging and ischemic conditions

  2019cites this paper
• Elucidating Conserved Transcriptional Networks Underlying Pesticide Exposure and Parkinson's Disease: A Focus on Chemicals of Epidemiological Relevance

  2019cites this paper
• Antiangiogenic Activity and Chemical Derivatization of the Neurotoxic Acetogenin Annonacin Isolated from Asimina triloba.

  2018cites this paper
• Can neuroimaging predict dementia in Parkinson’s disease?

  2018cites this paper
• P38 Mitogen-activated Protein Kinase and Parkinson’s Disease

  2018cites this paper
• Correlative atomic force microscopy quantitative imaging-laser scanning confocal microscopy quantifies the impact of stressors on live cells in real-time

  2018cites this paper